Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients with Type 2 Diabetes: A Randomized Trial

RATIONALE & OBJECTIVE: Hyperuricemia is implicated in the development and progression of chronic kidney disease (CKD). Verinurad is a novel, potent, specific urate reabsorption inhibitor. We evaluated the effects of intensive urate-lowering therapy with verinurad combined with the xanthine oxida...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Am J Kidney Dis
Egile Nagusiak: Stack, Austin G., Dronamraju, Nalina, Parkinson, Joanna, Johansson, Susanne, Johnsson, Eva, Erlandsson, Fredrik, Terkeltaub, Robert
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8045740/
https://ncbi.nlm.nih.gov/pubmed/33130235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.ajkd.2020.09.009
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak